Daniel D. Billadeau mainly focuses on Cell biology, Signal transduction, Cancer research, Receptor and T cell. His Cell biology study frequently links to other fields, such as Immunological synapse. His Cancer research research integrates issues from Gene silencing, Epigenetics, GSK-3 and Pancreatic cancer.
His research in Pancreatic cancer intersects with topics in Carcinogenesis and Cancer cell. His work focuses on many connections between Receptor and other disciplines, such as Immune recognition, that overlap with his field of interest in Microtubule, Signalling, VAV2 and Function. Daniel D. Billadeau has researched Actin in several fields, including Biophysics, Plasma protein binding and Cytoskeleton.
His main research concerns Cell biology, Cancer research, Signal transduction, Pancreatic cancer and GSK-3. The Cell biology study combines topics in areas such as T cell, Immunological synapse and T-cell receptor. His T cell research includes themes of Cytotoxic T cell and Phosphorylation.
In his research on the topic of Cancer research, Cell culture is strongly related with Cell growth. His studies deal with areas such as Carcinogenesis, SOX2, Transcription factor, Pancreas and Gemcitabine as well as Pancreatic cancer. His work on GSK3B as part of general GSK-3 research is frequently linked to XIAP, thereby connecting diverse disciplines of science.
His primary scientific interests are in Cell biology, Endosome, Cancer research, Pancreatic cancer and Phosphorylation. His Cell biology research incorporates themes from Chromatin and Endocytic recycling. His Endosome research incorporates elements of Phenotype, Phosphatase, Membrane protein and Zebrafish.
His work deals with themes such as Protein kinase B, GSK-3, SOX2, KRAS and Fibroblast growth factor receptor, which intersect with Cancer research. His biological study deals with issues like Gemcitabine, which deal with fields such as Oncology and Phases of clinical research. His study in Phosphorylation is interdisciplinary in nature, drawing from both Kinase and Actin nucleation.
Daniel D. Billadeau spends much of his time researching Cell biology, Endosome, Cancer research, WASH complex and Membrane protein. His work carried out in the field of Cell biology brings together such families of science as Nectin, Cell adhesion and Virus receptor. His Endosome research is multidisciplinary, incorporating perspectives in Mutation, Pontocerebellar hypoplasia, Mutant and Zebrafish.
The various areas that Daniel D. Billadeau examines in his Cancer research study include Pancreatic cancer, Kinase, GSK-3, Pancreatic disease and Tissue microarray. His WASH complex study incorporates themes from Vesicle, Cellular homeostasis, Organelle and Receptor recycling. His studies in Membrane protein integrate themes in fields like Signal transducing adaptor protein, Protein tyrosine phosphatase, Phosphatase, Protein subunit and Retromer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A FAM21-Containing WASH Complex Regulates Retromer-Dependent Sorting
Timothy S. Gomez;Daniel D. Billadeau.
Developmental Cell (2009)
Structure and control of the actin regulatory WAVE complex
Zhucheng Chen;Zhucheng Chen;Dominika Borek;Shae B. Padrick;Timothy S. Gomez.
NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway
Daniel D Billadeau;Jadee L Upshaw;Renee A Schoon;Christopher J Dick.
Nature Immunology (2003)
Regulation of T-cell activation by the cytoskeleton
Daniel D. Billadeau;Jeffrey C. Nolz;Timothy S. Gomez.
Nature Reviews Immunology (2007)
Glycogen Synthase Kinase-3β Participates in Nuclear Factor κB–Mediated Gene Transcription and Cell Survival in Pancreatic Cancer Cells
Andrei V. Ougolkov;Martin E. Fernandez-Zapico;Doris N. Savoy;Raul A. Urrutia.
Cancer Research (2005)
VAV proteins as signal integrators for multi-subunit immune-recognition receptors.
Martin Turner;Daniel D. Billadeau.
Nature Reviews Immunology (2002)
Vav1 Dephosphorylation by the Tyrosine Phosphatase SHP-1 as a Mechanism for Inhibition of Cellular Cytotoxicity
Christopher C. Stebbins;Carsten Watzl;Daniel D. Billadeau;Paul J. Leibson.
Molecular and Cellular Biology (2003)
SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells
M Herreros-Villanueva;J-S Zhang;A Koenig;A Koenig;E V Abel.
Deregulated GSK3β activity in colorectal cancer: Its association with tumor cell survival and proliferation
Abbas Shakoori;Andrei Ougolkov;Andrei Ougolkov;Zhi Wei Yu;Bin Zhang.
Biochemical and Biophysical Research Communications (2005)
NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells
Jadee L Upshaw;Laura N Arneson;Renee A Schoon;Christopher J Dick.
Nature Immunology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: